Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

321
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
321
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

737
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
737
Biostatistics: Overview01:20

Biostatistics: Overview

1.1K
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
1.1K
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

337
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
337
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

657
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
657
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

393
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
393

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial transcriptomics reveals clonal relationships between intraductal carcinoma and adjacent invasive prostate cancer.

Histopathology·2026
Same author

Normothermic versus hypothermic machine perfusion in kidney transplantation: A randomized controlled trial.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2025
Same author

Identifying gene expression signatures of oncolytic virus response in patient-derived pancreatic ductal adenocarcinoma organoids.

Molecular therapy. Oncology·2025
Same author

Expanding the Scope of Microvascular Inflammation: Unveiling Its Presence Beyond Antibody-Mediated Rejection Into T-Cell Mediated Contexts.

Transplant international : official journal of the European Society for Organ Transplantation·2025
Same author

Microbiology Galaxy Lab: The first community-driven gateway for reproducible and FAIR analysis of microbial data.

bioRxiv : the preprint server for biology·2025
Same author

The tumor immune microenvironment in resected treatment-naive pancreatic cancer patients with long-term survival.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2024

Related Experiment Video

Updated: Mar 27, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

5.9K

A contribution for cost models in biobanking.

Christine Huttin1,2, Andrew Stubbs3

  • 1ENDEPUSresearch, Inc., USA.

Technology and Health Care : Official Journal of the European Society for Engineering and Medicine
|January 13, 2016
PubMed
Summary
This summary is machine-generated.

This study explores financial sustainability for hospital biobanks by proposing new cost models beyond traditional recovery methods. It identifies cost drivers for optimizing resource allocation and enhancing adaptive platform development.

Keywords:
Cost driverscost modelshospital biobanksorganizational structure

More Related Videos

Sampling Strategies and Processing of Biobank Tissue Samples from Porcine Biomedical Models
05:07

Sampling Strategies and Processing of Biobank Tissue Samples from Porcine Biomedical Models

Published on: March 6, 2018

16.3K
Creation and Maintenance of a Living Biobank - How We Do It
13:08

Creation and Maintenance of a Living Biobank - How We Do It

Published on: April 10, 2021

8.2K

Related Experiment Videos

Last Updated: Mar 27, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

5.9K
Sampling Strategies and Processing of Biobank Tissue Samples from Porcine Biomedical Models
05:07

Sampling Strategies and Processing of Biobank Tissue Samples from Porcine Biomedical Models

Published on: March 6, 2018

16.3K
Creation and Maintenance of a Living Biobank - How We Do It
13:08

Creation and Maintenance of a Living Biobank - How We Do It

Published on: April 10, 2021

8.2K

Area of Science:

  • Biomedical informatics
  • Health economics
  • Biobanking management

Background:

  • Financial sustainability is a critical challenge for hospital biobanks and biospecimen data warehouses.
  • Conventional cost recovery models may not adequately address the complexities of biobanking operations.
  • Previous work highlighted adaptive platforms for biobanks in translational medicine.

Purpose of the Study:

  • To discuss novel cost models for ensuring the financial sustainability of hospital biobanks.
  • To identify key cost drivers for optimizing resource allocation within these institutions.
  • To facilitate collaboration between biobank managers and adaptive platform designers.

Main Methods:

  • A case study approach was employed to analyze cost structures.
  • Identification of essential cost drivers for resource allocation optimization.
  • Exploration of new cost modeling strategies beyond traditional methods.

Main Results:

  • The study proposes a framework for understanding and managing cost drivers in hospital biobanks.
  • Identified specific cost elements crucial for optimizing resource allocation.
  • Highlighted the need for integrated cost data in adaptive platform design.

Conclusions:

  • Implementing innovative cost models is essential for the financial sustainability of hospital biobanks.
  • Understanding cost drivers enables efficient resource allocation and operational optimization.
  • This research supports the development of adaptive platforms by providing data on biobank economics.